Segment and Geographical Data (Tables)

12 Months Ended

Dec. 27, 2024

Schedule of Segment Reporting Information by Business Segment

Selected information by reportable segment was as follows:

Schedule of Net Sales from External Customers by Products

Net sales by product family within the Company's reportable segments were as follows:


	Successor				Predecessor
	Year Ended December 27, 2024		Period from November 15, 2023 through December 29, 2023		Period from December 31, 2022 through November 14, 2023		Period from June 17, 2022 through December 30, 2022		Period from January 1, 2022 through June 16, 2022
Acthar Gel	$	485.7	$	57.0	$	368.3	$	294.1	$	221.9
INOmax	261.4		35.3		267.9		173.9		165.8
Therakos	241.6		39.1		220.0		130.5		109.6
Amitiza (1)	62.9		5.0		72.0		77.1		81.5
Terlivaz	24.7		2.3		13.3		1.2		—
Other	7.1		1.1		7.7		5.6		8.3
Specialty Brands	1,083.4		139.8		949.2		682.4		587.1

Opioids	349.9		31.6		230.7		117.9		88.8
ADHD	166.2		13.5		101.4		28.4		17.5
Addiction treatment	75.3		10.5		55.6		35.0		30.0
Other	8.1		1.6		8.2		6.8		4.9
Generics	599.5		57.2		395.9		188.1		141.2
Controlled substances	98.7		11.6		75.5		47.0		37.6
APAP	177.8		32.5		184.8		111.4		96.5
Other	20.3		1.9		17.5		10.8		12.2
API	296.8		46.0		277.8		169.2		146.3
Specialty Generics	896.3		103.2		673.7		357.3		287.5
Net Sales	$	1,979.7	$	243.0	$	1,622.9	$	1,039.7	$	874.6

(1)Amitiza net sales consist of both product and royalty net sales.

Schedule of Net Sales and Long-Lived Assets by Geographical Area

Selected information by geographic area was as follows:


	Successor				Predecessor
	Year Ended December 27, 2024		Period from November 15, 2023 through December 29, 2023		Period from December 31, 2022 through November 14, 2023		Period from June 17, 2022 through December 30, 2022		Period from January 1, 2022 through June 16, 2022
Net sales (1):
U.S.	$	1,802.6	$	212.8	$	1,448.9	$	928.3	$	784.2
Europe, Middle East and Africa	162.1		28.8		157.1		100.4		73.6
Other	15.0		1.4		16.9		11.0		16.8
Net Sales	$	1,979.7	$	243.0	$	1,622.9	$	1,039.7	$	874.6

(1)Net sales are attributed to regions based on the location of the entity that records the transaction, none of which relate to the country of Ireland.


	Successor				Predecessor
	December 27, 2024		December 29, 2023		December 30, 2022
Long-lived assets (1):
U.S.	$	339.5	$	165.9	$	287.3
Europe, Middle East and Africa (2)	62.3		164.6		178.0
Other	1.2		2.8		3.1
	$	403.0	$	333.3	$	468.4

(1)Long-lived assets are primarily composed of property, plant and equipment, net.

(2)Includes long-lived assets located in Ireland of $62.3 million, $162.1 million and $174.9 million as of December 27, 2024 (Successor), December 29, 2023 (Successor) and December 30, 2022 (Predecessor), respectively.

^[1]

[1]	Net sales are attributed to regions based on the location of the entity that records the transaction, none of which relate to the country of Ireland.